Chambal Fertilisers and Chemicals (CHAMBLFERT) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
2 Aug, 2026Executive summary
Q1 FY27 saw challenging conditions from geopolitical disruptions, elevated raw material prices, delayed monsoon, and planned plant shutdowns, impacting fertilizer demand and supply chains.
Despite these headwinds, improved profitability was achieved through prudent procurement, product launches, and a diversified portfolio, with margin gains across CPC, SN, and biologicals.
The company maintains a strong pan-India presence with a 10% urea market share and robust distribution.
Government engagement ensured gas availability, timely subsidy disbursements, and uninterrupted operations.
Preparatory activities for a potential fourth urea plant are underway, pending board approval.
Financial highlights
Standalone revenue from operations was INR 5,027.02 crore, down 12% year-over-year, with consolidated revenue at INR 5,027.02 crore.
EBITDA rose 12% to INR 851 crore, with margins expanding to 17% from 13% (up 350 bps).
Standalone net profit was INR 703.49 crore, up from the previous quarter but down from INR 758.68 crore YoY; consolidated net profit was INR 523.61 crore.
Subsidy received was INR 2,480 crore, nearly flat year-over-year.
Net borrowing stood at INR 200 crore as of June 30, with net debt to equity at 0.01.
Outlook and guidance
Improved monsoon and sowing activity are expected to drive stronger demand in Q2 and the remainder of the year.
Long-term outlook remains constructive, with the National Investment Policy for Urea 2026 supporting future capacity expansion.
Management expects continued growth in value-added businesses and successful ramp-up of the TAN project.
Financial statements are based on current government policies and notified concession rates for fertiliser subsidies.
Latest events from Chambal Fertilisers and Chemicals
- FY26 saw 25% revenue growth, 18% profit rise, and major TAN plant commissioning.CHAMBLFERT
Q4 25/26 - Diversified agri-input leader with strong financials, expanding into industrial chemicals and sustainability.CHAMBLFERT
Investor presentation - Strong Q3/9M growth driven by complex fertilizers, specialty nutrients, and TAN project progress.CHAMBLFERT
Q3 25/26 - Strong revenue and profit growth, new launches, and interim dividend highlight robust performance.CHAMBLFERT
Q2 25/26 - EBITDA and PAT rose sharply, with zero long-term debt and strong crop protection growth.CHAMBLFERT
Q1 24/25 - EBITDA and PAT surged year-over-year, supported by urea and CPCSM growth, and interim dividend declared.CHAMBLFERT
Q2 24/25 - Q3 saw strong profit and revenue growth, new product launches, and major capacity expansions.CHAMBLFERT
Q3 24/25 - EBITDA and PAT rose in FY25, led by CPC & SN growth; Rs. 5.00/share dividend recommended.CHAMBLFERT
Q4 24/25 - Profits and revenue rose on CPC, SN, and biologicals growth; TAN project 80% complete.CHAMBLFERT
Q1 25/26